Current mechanistic approaches to the chemoprevention of cancer

Journal of Biochemistry and Molecular Biology

Volumn 36, Issue 1, 2003, Pages 78-81

  Steele, Vernon E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Anticancer; Antimutagenesis; Chemoprevention; Chemoprotection; Nonsteroidal antiinflammatory drugs

Indexed keywords

3 INDOLEMETHANOL; ACETYLCYSTEINE; ANASTROZOLE; ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; BUDESONIDE; CALCIUM ANTAGONIST; CELECOXIB; EFLORNITHINE; FINASTERIDE; FLUTAMIDE; FOLIC ACID ANTAGONIST; GENISTEIN; ISOFLAVONE DERIVATIVE; LASOFOXIFENE; NONSTEROID ANTIINFLAMMATORY AGENT; OLTIPRAZ; PROTEINASE INHIBITOR; RETINOID DERIVATIVE; TAMOXIFEN; UNCLASSIFIED DRUG; USODIOL; VOROZOLE; ANTIOXIDANT; DNA TOPOISOMERASE; ENZYME INHIBITOR; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

APOPTOSIS; CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DIVISION; CELL PROTECTION; CHEMOPROPHYLAXIS; CLINICAL PATHWAY; CLONE; DNA SYNTHESIS; DRUG MECHANISM; HUMAN; MEDICAL RESEARCH; ONCOGENE; PRECANCER; REGULATORY MECHANISM; REVIEW; TUMOR PROMOTION; TUMOR SUPPRESSOR GENE; ANIMAL; DNA METHYLATION; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; METABOLISM; NEOPLASM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; CELL DIVISION; CHEMOPREVENTION; CYCLOOXYGENASE INHIBITORS; DNA METHYLATION; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; NEOPLASMS; ONCOGENES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SELECTIVE ESTROGEN RECEPTOR MODULATORS;

EID: 0038544193     PISSN: 12258687     EISSN: None     Source Type: Journal    
DOI: 10.5483/bmbrep.2003.36.1.078     Document Type: Review

References (27)

1. Altucci, L. and Gronemeyer, H. (2001) The promise of retinoids to fight against cancer. Nat. Rev. Cancer 1, 181-193.
2. Boone, C. W., Kelloff, G. J. and Steele, V. E. (1992) The natural history of intraepithelial neoplasia in humans with implications for cancer chemoprevention strategy. Cancer Res. 52, 1651-1659.
3. Chen, G., Wilson, R., McKillop, J. H. and Walker, J. J. (1994) The role of cytokines in the production of prostacyclin and thromboxane in human mononuclear cells. Immunol. Invest. 23, 269-279.
4. Cho, K. H., Pezzuto, J. M., Bolton, J. L., Steele, V. E., Kelloff, G. J., Lee, S. K. and Constantinou, A. (2000) Selection of Cancer chemopreventive agents based in inhibition of topoisomerase II activity. Eur. J. Cancer 36, 2146-2156.
5. Cohen, L. A., Pittman, B., Wang, C. X., Aliaga, C. and Moyer, J. D. (2001) LAS, a novel selective estrogen receptor modulator with chemopreventive and therapeutic activity in the N-nitroso-N-methylurea-induced rat mammary tumor model. Cancer Res. 61, 8683-8686.
6. Dardes, R. C., O'Regan, R. M., Gajdos, C., Robinson, S. P., Bentrem, D., De Los Reyes, A. and Jordan, V. C. (2002) Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Clin. Cancer Res. 8, 1995-2001.
7. Dobbs, S. P., Hewett, P. W., Johnson, I. R., Carmichael, J. and Murray, J. C. (1997) Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia. Br. J. Cancer 76, 1410-1415.
8. DuBois, R. N., Tsujii, M., Bishop, P., Awad, J. A., Makita, K. and Lanahan, A. (1994) Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol. 266, 822-827.
9. Egner, P. A., Wang, J. B., Zhu, Y. R., Zhang, B. C., Wu, Y., Zhang, Q. N., Qian, G. S., Kuang, S. Y., Gange, S. J., Jacobson, L. P., Helzlsouer, K. J., Bailey, G. S., Groopman, J. D. and Kensler, T. W. (2001) Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc. Natl. Acad. Sci. USA 98, 14601-14606.
10. Garcia, S. B., Novelli, M. and Wright, N. A. (2000) The clonal origin and clonal evolution of epithelial tumours. Int. J. Exp. Pathol. 81, 89-116.
11. Hecht, S. S. (2002) Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol. 3, 461-469.
12. Hempel, S. L., Monick, M. M. and Hunninghake, G. W. (1994) Lipopolysaccharide induces prostaglandin H synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes. J. Clin. Invest. 93, 391-396.
13. Kelloff, G. J., Lubet, R. A., Lieberman, R., Eisenhauer, K., Steele, V. E., Crowell, J. A., Hawk, E. T, Boone, C. W. and Sigman, C. C. (1998) Aromatase inhibitors as potential cancer chemopreventives. Cancer Epidemiol. Biomarkers & Prev. 7, 65-78.
14. Newmark, H. L., Wargovich, M. J. and Bruce, W. R. (1984) Colon cancer and dietary fat calcium and phosphate: a hypothesis. J. Natl. Cancer Inst. 72, 1323-1325.
15. Prescott, S. M. and White, R. L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell 87, 783-786.
16. Ristimaki, A., Garfinkel, S., Wessendoff, J., Maciag, T. and Hla, T. (1994) Induction of cyclooxygenase-2 by interleukin-1. Evidence for post-transcriptional regulation. J. Biol. Chem. 269, 11769-11775.
17. Robertson, J. F. (2001) Faslodex (ICI 182,780), a novel estrogen receptor down regulator-future possibilities in breast cancer. J. Steroid Biochem. Mol. Biol. 79, 209-212.
18. Scharovsky, O. G., Rozados, V. R., Gervasoni, S. I. and Matar, P. (2000) Inhibition of ras oncogene: a novel approach to antineoplastic therapy. J. Biomed. Sci. 7, 292-298.
19. Sharma, S., Ghoddoussi, M., Gao, P,. Kelloff, G. J., Steele, V. E. and Kopelovich, L. (2001) A quantitative angiogenesis model for efficacy testing of chemopreventive agents. Anticancer Res. 21, 3829-3838.
20. Smith, W. L., Garavito, R. M. and DeWitt, D. L. (1996) Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and -2. J. Biol. Chem. 271, 33157-33160.
21. Steele, V. E., Kelloff, G. J., Balentine, D., Boone, C. W., Mehta, R., Bagheri, D., Sigman, C. C., Zhu, S. and Sharma, S. (2000) Comparative chemopreventive mechanisms of green tea, black tea, and selected polphenol extracts measured by in vitro bioassays. Carcinogenesis 21, 63-67.
22. Sun, S. Y. and Lotan, R. (2002) Retinoids and their receptors in cancer development and chemoprevention. Crit. Rev. Oncol. Hematol. 41, 41-55.
23. Tao, L., Li, Y., Wang, W., Kramer, P. M., Gunning, W. T., Lubet, R. A., Steele, V. E. and Pereira, M. A. (2002) Effect of budesonide on the methylation of mRNA expression of the insulin-like growth factor 2 and c-myc genes in mouse lung tumors. Mol. Carcinog. 35, 93-102.
24. Voest, E. E. (1996) Inhibitors of angiogenesis in a clinical perspective. Anticancer Drugs 7, 723-727.
25. Wargovich, M. J., Eng, V. W. S., Newmark, H. L. and Bruce, W. R. (1983) Calcium ameliorates the toxic effects of deoxycholic acid on colonic epithelium. Carcinogenesis 4, 1205-1207.
26. Williams, C. S. and DuBois, R. N. (1996) Prostaglandin endoperoxide synthase: Why two isoforms? Am. J. Physiol. 270, 393-400.
27. Wolf, C. R., Mahmood, A., Henderson, C. J., McLeod, R., Manson, M. M., Neal, G. E. and Hayes, J. D. (1996) Modulation of the cytochrome P450 system as a mechanism of chemoprotection. IARC Sci. Publ. 139, 165-173.